Company Details
HilleVax
321 Harrison Ave, 5th Fl, Boston, Massachusetts, 02118, United States
Overview
HilleVax was created by Takeda and Frazier and is described as a newly born legacy biotech. The company is advancing a late-stage vaccine program. Rob Hershberg is named as HilleVax’s CEO. The article reports that HilleVax has raised $135M. It has also enlisted an A-list board to support its development efforts. The coverage frames the company as part of Tachi’s legacy biotechs continuing to make news.
- Total raised
- $135M
- Funding rounds
- 1
- Latest round
- Equity
- Latest activity
- Sep 2021
Industries
- Biopharma
- Biotechnology
- Health Care
- Pharmaceutical
Recent funding
Equity
Sep 2021
$135M